In this study, we investigated the anti-inflammatory and
tumor-inhibiting effects of
eburicoic acid, the main bioactive component in the Laetiporus sulphureus, on
gastric ulcers. A total of 48 Kunming mice were randomly divided into six groups: control, model, OL (
omeprazole, 20 mg/kg/day, orally), EA-L (
eburicoic acid, 10 mg/kg/day, orally), EA-M (
eburicoic acid, 20 mg/kg/day, orally), and EA-H (
eburicoic acid, 40 mg/kg/day, orally).
Gastric ulcers were induced in mice by administering 80%
ethanol containing 15 mg/mL
aspirin (10.0 mL/kg, i.g.) 4 hours after
drug administration on day 5. The
ulcer index and H+/K+-
ATPase activity were evaluated in vivo. Computer-aided molecular docking simulated the interaction between
eburicoic acid and H+/K+-
ATPase. The results showed that the
oral administration of
eburicoic acid protected the gastric mucosa from gastric lesions morphologically and especially attenuated H+/K+-
ATPase activity. The results of this study indicate that the gastric protective effect of
eburicoic acid might inhibit gastric acid.